A Study of a New Leishmania Vaccine Candidate ChAd63-KH

Clinical trial NCT02894008 · COMPLETED

Trial details

NCT number: NCT02894008
Sponsor: University of York
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Leishmaniasis, Cutaneous

Start date: 2016-11-01
Primary completion: 2019-09-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.